Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sudden cardiac death.

J Sra1, A Dhala, Z Blanck

  • 1University of Wisconsin Medical School, St Luke's Medical Center, Milwaukee, USA.

Current Problems in Cardiology
|August 25, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Presence of obesity is associated with lower mortality in elderly patients with implantable cardioverter defibrillator.

International journal of obesity (2005)·2017
Same author

Pulmonary disease in rescue workers at the World Trade Center site.

Current opinion in pulmonary medicine·2005
Same author

Implantable cardioverter defibrillator therapy in children with long QT syndrome.

Pediatric cardiology·2004
Same author

Cost-effectiveness of Project ADAM: a project to prevent sudden cardiac death in high school students.

Pediatric cardiology·2004
Same author

Electroanatomically guided catheter ablation of ventricular tachycardias causing multiple defibrillator shocks.

Pacing and clinical electrophysiology : PACE·2002
Same author

Correlation of spontaneous and induced premature atrial complexes initiating atrial fibrillation in humans: electrophysiologic parameters for guiding therapy.

Journal of cardiovascular electrophysiology·2002

Sudden cardiac death (SCD) remains a significant health concern. While identifying high-risk individuals and non-ischemic causes is challenging, advancements in therapies like implantable cardioverter-defibrillators (ICDs) improve survival for those with ventricular tachycardia/fibrillation (VT/VF).

Area of Science:

  • Cardiology
  • Medical Research
  • Public Health

Background:

  • Sudden cardiac death (SCD) remains a leading cause of mortality and morbidity.
  • Current methods for identifying individuals at high risk for SCD are insufficient.
  • Understanding the mechanisms of SCD is crucial for effective prevention and treatment strategies.

Purpose of the Study:

  • To review current understanding and management strategies for sudden cardiac death (SCD).
  • To highlight the role of emerging therapies, such as implantable cardioverter-defibrillators (ICDs), in preventing SCD.
  • To discuss the challenges in identifying at-risk populations, particularly those with non-ischemic substrates.

Main Methods:

  • Review of recent clinical trials and data (e.g., MADIT, AVID studies) on SCD prevention therapies.

Related Experiment Videos

  • Analysis of the efficacy of various interventions, including pharmacologic agents and device-based therapies.
  • Exploration of ongoing research into genetic factors and mechanisms underlying SCD.

    • Main Results:

    • Implantable cardioverter-defibrillators (ICDs) demonstrate significant benefit in patients with ventricular tachycardia/fibrillation (VT/VF) at risk of cardiac arrest.
    • Established therapies like aspirin, ACE inhibitors, beta-blockers, and statins are vital for primary prevention and post-myocardial infarction care.
    • Aggressive anti-ischemic and heart failure management, alongside ICDs, are key for high-risk populations.

    Conclusions:

    • ICDs are a cornerstone of life-saving treatment for specific high-risk SCD patient groups.
    • Continued research is needed to identify patients with non-ischemic SCD and develop targeted therapies.
    • Genetic studies and a deeper understanding of SCD mechanisms promise future advancements in prevention and management.